Compare · INMD vs NTUS
INMD vs NTUS
Side-by-side comparison of InMode Ltd. (INMD) and Natus Medical Incorporated (NTUS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INMD and NTUS operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- INMD is the larger of the two at $912.4M, about 1.2x NTUS ($761.9M).
- INMD has hit the wire 1 time in the past 4 weeks while NTUS has been quiet.
- INMD has more recent analyst coverage (20 ratings vs 0 for NTUS).
- Company
- InMode Ltd.
- Natus Medical Incorporated
- Price
- $14.40+0.14%
- $32.97+0.12%
- Market cap
- $912.4M
- $761.9M
- 1M return
- +4.80%
- -
- 1Y return
- +1.02%
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- News (4w)
- 1
- 0
- Recent ratings
- 20
- 0
InMode Ltd.
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.
Natus Medical Incorporated
Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was founded in 1987 and is headquartered in Pleasanton, California.
Latest INMD
- InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
- InMode to Present at the 25th Annual Needham Virtual Healthcare Conference
- SEC Form 3 filed by InMode Ltd.
- SEC Form 3 filed by InMode Ltd.
- SEC Form 3 filed by new insider Mizrahy Moshe
- SEC Form 3 filed by new insider Kreindel Michael
- SEC Form 3 filed by InMode Ltd.
- SEC Form 3 filed by InMode Ltd.
- SEC Form 3 filed by InMode Ltd.
- SEC Form 6-K filed by InMode Ltd.
Latest NTUS
- Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
- SEC Form 15-12G filed by Natus Medical Incorporated
- SEC Form EFFECT filed by Natus Medical Incorporated
- SEC Form EFFECT filed by Natus Medical Incorporated
- SEC Form EFFECT filed by Natus Medical Incorporated
- Novanta Shares Pop On Inclusion Into S&P MidCap 400
- Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600
- SEC Form 4: Schroeder Alice D. returned $750,601 worth of shares to the company (22,406 units at $33.50), closing all direct ownership in the company (for withholding tax)
- SEC Form 4: Moore Bryant M returned $338,819 worth of shares to the company (10,114 units at $33.50), closing all direct ownership in the company (withholding obligation)
- SEC Form 4: Levine Joshua returned $1,252,464 worth of shares to the company (37,387 units at $33.50), closing all direct ownership in the company to cover taxes